12/10/2007 - 13:10

Imugene's porcine patent protected until 2021 in USA

12/10/2007 - 13:10

Bookmark

Save articles for future reference.

Perth biotechnology company Imugene Ltd has received notice of grant for patent protection for its Porcine Adenoviral Delivery Vector technology in the United States of America, the company has announced.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options